Williams could be on her way back to the court after being listed by the International Tennis Integrity Agency as eligible to return on Feb. 22.

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial data.

Serena Williams passed another stage on the path to a possible comeback to professional tennis, being listed Monday by the sport's drug-testing organization as eligible to return to competition on Feb ...

The Danish drugmaker’s patent lawsuit is the company’s latest effort to shore up its place in the booming weight-loss drug ...

Hims & Hers Health shares plunged Monday after the telehealth company said it would stop selling its compounded weight-loss ...

Weight loss drugs are the thing of the moment. But what happens when they shrink our friendships and dating lives along with ...

There are over 20,000 prescription drugs approved by the Food and Drug Administration (FDA). The number of medical ...

Here's guidance the FDA offers for patients whose prescriptions for this generic alternative could be affected.

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

TrumpRx.gov is now live in California, offering discounted cash‑pay prices on 40+ meds. Here’s how it works and who benefits ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.